-
Cannabics Pharmaceuticals Announces Two New Provisional Patents: Compositions and Methods For Treating Cancer
Monday, October 18, 2021 - 12:49pm | 270Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer-related cannabinoid-based medicine, announced on Monday that it has filed two new provisional patent applications on Compositions and Methods for treating cancer, including colorectal cancer and early...
-
'Algorithms Manage Everything': One Israeli Company's Mission To Make Marijuana Growing Effortless
Wednesday, July 17, 2019 - 12:30pm | 911The state-by-state legalization of cannabis has made thousands of strains legally available. Many cannabis users still find growing their own weed appealing — and others may have the need to grow cannabis due to a lack of nearby dispensaries. Cannabis cultivation is a meticulous process that...
-
4 Questions With Cannabics Pharmaceuticals CEO Eyal Barad
Friday, July 13, 2018 - 12:40pm | 949Cannabics Pharmaceuticals Inc (OTC: CNBX) is an Israel-based bio-pharma company focused on the development of “precision medicine, personalized anti-cancer diagnostics and cannabis-based treatments.” While there are currently no products sold under the Cannabics brand, the company does...